BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Pseudomonas infection
,
Liver
,
Personalized medicine
,
Doxorubicin
,
rs2300478
,
ERBB2
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
glycogen storage disease type ii
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
PRUNE2
XIST
IGFN1
MEG3
CHI3L1
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
vesicle
extracellular vesicle
cytoplasmic vesicle
intracellular vesicle
REN_ALVEOLAR_RHABDOMYOSARCOMA_DN
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Pompe disease-induced pluripotent stem cells and derivative cardiomyocyte-like cells
Biceps and quadriceps of infantile-onset Pompe disease patients treated with acid alpha-glucosidase
Mouse Phenotypes - Myopathy
Explore Curated Studies Results
Literature
Most Relevant Literature
Systemic metabolic abnormalities in adult-onset acid maltase deficiency: beyond muscle glycogen accu…
Myalgic phenotype and preserved muscle strength in adult-onset acid maltase deficiency.
Exercise testing in late-onset glycogen storage disease type II patients undergoing enzyme replaceme…
Acid maltase deficiency--Pompe's disease.
Pregnancy during enzyme replacement therapy for late-onset acid maltase deficiency.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study of the Safety and Pharmacokinetics of rhGAA in Siblings With Glycogen Storage Disease Type I…
Biomarker for Glycogen Storage Diseases (BioGlycogen)
rhGAA in Patients With Infantile-onset Glycogen Storage Disease-II (Pompe Disease)
Carbon-13 Magnetic Resonance Spectroscopy in Glycogen Storage Diseases
A Prospective, Observational Study in Patients With Late-Onset Pompe Disease
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ